Spr1814 of Streptococcus pneumoniae is a signal transduction response regulator belonging to the NarL/FixJ subfamily, which has a helix-turn-helix DNAbinding effector domain. To understand how the phosphorylation of the conserved aspartic acid residue induces conformational changes in spr1814 allowing binding to the target promoter, recombinant spr1814 expressed in Escherichia coli was crystallized with the phosphoryl analogue beryllium fluoride BeF 3 À by the hanging-drop vapour-diffusion method. The crystals diffracted to 1.9 Å resolution and belonged to space group P2 1 , with unit-cell parameters a = 40.2, b = 114.5, c = 50.1 Å , = 92.1 . Structure determination by the SAD method using the bromine derivative 5-amino-2,4,6-tribromoisophthalic acid (B3C) is under way.
Introduction
Two-component systems (TCS) are regulatory mechanisms that are ubiquitous among bacteria (Parkinson & Kofoid, 1992; Stock et al., 1989) . These systems regulate many processes, including cell-cell communication, adaptation to the environment and, in the case of pathogens, pathogenesis (Stock et al., 2000) . Because of their absence in humans and other mammals, TCS proteins are considered to be suitable targets for the development of new antibiotics. In their simplest form, TCS consist of two modular proteins: a sensory histidine kinase (HK) and a response regulator (RR) (Parkinson & Kofoid, 1992) . The HK senses specific environmental signals which ultimately lead to activation of the kinase activity and autophosphorylation of a conserved histidine residue (Gao & Stock, 2009 ). The phosphoryl group is subsequently transferred to a conserved aspartic acid residue in the receiver domain of the cognate RR for activation. Most RRs are transcription factors which activate or repress a particular set of genes (Gao & Stock, 2009 ). Spr1814, the RR studied here, consists of two domains: a conserved N-terminal receiver domain and a C-terminal effector domain which can bind to DNA. According to the structure of the DNA-binding domain, spr1814 belongs to the NarL/FixJ subfamily, which is characterized by a helix-turn-helix (HTH) DNA-binding domain (Baikalov et al., 1996; Kurashima-Ito et al., 2005) . Structural information regarding RRs belonging to the NarL/FixJ subfamily has suggested that they may be activated by domain rearrangements, disrupting the interdomain contacts, upon phosphorylation (Hoch, 2000; Baikalov et al., 1996) . The conformational change induced by phosphorylation results in dimerization of the RR and binding of the dimer to the promoter of target genes.
Our previously reported structure of the full-length unphosphorylated spr1814 (PDB entry 4hye, Park et al., 2013) shows that there are two monomers displaying distinct conformations in the asymmetric unit. While one monomer adopts an inactive conformation, the other exhibits an intermediate conformation. The receiver domain of the monomer in the inactive conformation showed two conserved switch residues, Thr81 and Tyr100, oriented away from the phosphorylation site. On the other hand, the active-like conformation was observed in the intermediate state, in which the two residues point toward the phosphorylation site. In terms of domain contacts, when in the inactive state the receiver and effector domain display interdomain contacts resulting in inhibition of the binding of the effector domain to its target promoter, while the effector domain was somewhat released from the receiver domain in the intermediate state. This movement of the effector domain in the intermediate state was achieved by a flexible linker region which connects the two domains and is made up of an extended loop and short -helix.
The fact that the linker region plays an important role in domain reorganization was further supported by an earlier structural study of the receiver domain of spr1814 in the presence and absence of the phosphoryl analogue beryllium fluoride BeF 3 À (PDB entries 4e7o and 4e7p), which demonstrated conformational changes of the linker region upon phosphorylation (Park et al., 2012) . However, to understand how these conformational changes allow RRs to bind to and regulate the target promoter, it is necessary to determine the fulllength structure of phosphorylated RRs.
Here, we report the crystallization and preliminary X-ray crystallographic analysis of full-length spr1814 from Streptococcus pneumoniae in complex with the phosphoryl analogue BeF 3 À (Yan et al., 1999) , providing a first step towards the elucidation of the regulatory mechanism employed by spr1814. The experimental phasing was obtained by single-wavelength anomalous dispersion (SAD) using 5amino-2,4,6-tribromoisophthalic acid (B3C; Beck et al., 2009 ). B3C contains three functional groups (two carboxylate groups and one amino group) that interact with proteins via hydrogen bonds, and three Br atoms suitable for anomalous dispersion phasing (Beck et al., 2010) . The B3C molecules bound to the proteins provide a strong anomalous signal which can be used for MAD (multiwavelength anomalous diffraction) phasing (Beck et al., 2010) .
Materials and methods

Protein expression and purification
Full-length spr1814 (formerly known as DesR) was overexpressed and purified using previously described methods (Park et al., 2009) . Briefly, the full-length spr1814 gene (UniProtKB/TrEMBL accession No. Q8DNC2) was amplified from S. pneumoniae genomic DNA by polymerase chain reaction (PCR). Recombinant plasmid bearing the spr1814 gene was transformed into the Escherichia coli BL21 (DE3) strain and the cells were grown in Luria-Bertani medium. Expression was then induced with 0.2 mM isopropyl -d-1-thiogalactopyranoside (IPTG). After centrifugation, the cell pellets were resuspended in buffer A (20 mM Tris-HCl pH 7.9, 500 mM NaCl, 5 mM imidazole) and lysed by sonication. The supernatant was loaded onto an Ni 2+chelated HiTrap chelating HP column (GE Healthcare, USA) and the proteins were eluted with a linear gradient of buffer A containing 1 M imidazole. The protein was further purified by gel filtration on a HiLoad 16/60 Superdex 200 column (GE Healthcare, USA) which was pre-equilibrated with buffer B (20 mM Tris-HCl pH 7.9, 200 mM NaCl, 5 mM MgCl 2 , 2 mM DTT, 10% glycerol). The purified protein was concentrated to 18 mg ml À1 using an Amicon Ultra-15 ultrafiltration device (Millipore, USA), yielding 20 mg protein per litre of medium (Fig. 1) .
Crystallization
For co-crystallization with BeF 3 À , the protein was incubated with 30 mM NaF and 5 mM BeCl 2 for 30 min on ice and then centrifuged at 20 000g for 10 min to remove the precipitated protein. The protein concentration was 15 mg ml À1 after centrifugation. Initial crystallization screening was performed in 96-well Intelli-Plates (Art Robbins Instruments, USA) at 295 K by the sitting-drop vapourdiffusion method (0.5 ml protein solution and 0.5 ml reservoir solution equilibrated against 70 ml reservoir solution), which was performed by hand using electronic pipettes. Commercial screening kits such as . However, processing of the diffraction data acquired from the crystals was problematic because of twinning. In order to optimize the crystals, additive screening was carried out using Additive Screen (Hampton Research, USA) . For the additive screen, 0.2 ml of the additives were added to 1 ml protein solution and 1 ml reservoir solution and the drops were equilibrated against 500 ml reservoir solution in 24-well VDX hanging-drop plates. After the first round of the additive screen, additive 31 [30%(w/v) 1,5-diaminopentane dihydrochloride] was found to improve the crystal morphology, but the crystals formed were still twinned. For further optimization, 3%(w/v) 1,5-diaminopentane dihydrochloride was added to the protein solution, along with 30 mM NaF and 5 mM BeCl 2 . The original additive screen was then repeated. Additive 85 [10%(v/v) 1,2-butanediol] yielded suitable crystals for collection of the diffraction data within one week under the following conditions: 0.1 M sodium citrate tribasic dihydrate pH 4.7, 18%(v/v) Jeffamine ED-2001 pH 7.0 ( Fig. 2a) .
For SAD phasing, a 1 M stock solution of B3C was obtained by dissolving the solid material in 2 M lithium hydroxide solution (Beck et al., 2010) . The B3C stock solution was added to the protein solution to produce a final concentration of 0.2 M B3C along with 30 mM NaF, 5 mM BeCl 2 , 3%(w/v) 1,5-diaminopentane dihydrochloride. The incorporation of the B3C molecule in the proteins allowed the formation of single crystals without a second additive screen. Crystals were obtained under the same conditions used to produce the BeF 3 À complex crystals (Fig. 2b) .
X-ray data collection
Both the BeF 3 À and BeF 3 À -B3C-spr1814 ternary-complex crystals were cryoprotected by the introduction of 20%(v/v) ethylene glycol. X-ray diffraction data for the BeF 3 À complex crystals were collected at a resolution of 1.9 Å using an ADSC Quantum 210 CCD detector on beamline AR-NW12 at the Photon Factory, Tsukuba, Japan. The wavelength of the synchrotron X-rays was 1.0000 Å . For the BeF 3 À -B3C-spr1814 ternary-complex crystals, X-ray diffraction data were collected at a resolution of 2.0 Å using an ADSC Quantum 210 CCD detector on beamline 7A at the Pohang Light Source, Pohang, Republic of Korea. The subsequent SAD data were collected at the peak wavelength ( = 0.9198 Å ) of the Br K-edge absorption profile.
A total range of 360 was covered with 1.0 oscillation for both crystals. All data sets were indexed, processed and scaled using the HKL-2000 software package (Otwinowski & Minor, 1997) . Table 1 provides a summary of the data-collection statistics.
Results and discussion
The full-length spr1814 was successfully cloned, overexpressed and obtained at high purity by affinity and size-exclusion chromatography. To obtain spr1814 crystals in the phosphorylated state, crystallization trials were carried out in which spr1814 was complexed with the phosphoryl analogue beryllium fluoride BeF 3 À . Crystals of spr1814 complexed with BeF 3 À were obtained after subsequent additive screening and they diffracted to 1.9 Å resolution. Initial diffraction analysis of the optimized crystals showed that they belonged to space group P2 1 , with unit-cell parameters a = 40.2, b = 114.5, c = 50.1 Å , = 92.1 . The Matthews coefficient (Matthews, 1968 ) calculated for a crystal containing a dimer in the asymmetric unit was 2.59 Å 3 Da À1 , with a solvent content of 52.47%.
All attempts to solve the structure by the molecular-replacement method using the full-length structure of unphosphorylated spr1814 (PDB entry 4hye; Park et al., 2013 ) as a search model failed. In addition, the selenomethionine-substituted protein did not provide crystals of sufficient quality to allow the collection of diffraction data. In order to solve the phase problem by the single-wavelength anomalous diffraction method, 5-amino-2,4,6-tribromoisophthalic acid (B3C; Beck et al., 2009 ) was used for co-crystallization with the proteins and the structure is currently being refined. Initial diffraction analysis of the BeF 3 À -B3C-spr1814 ternary-complex crystals showed that they belonged to space group P2 1 , with unit-cell parameters a = 40.9, b = 115.5, c = 50.1 Å , = 92.4 . Assuming the presence of a dimer in the asymmetric unit in the crystals, the Matthews coefficient (Matthews, 1968 ) was calculated to be 2.66 Å 3 Da À1 , with a solvent content of 53.67%. 
